162 related articles for article (PubMed ID: 24509250)
21. Human intestinal epithelial response(s) to Clostridium difficile.
Jafari NV; Allan E; Bajaj-Elliott M
Methods Mol Biol; 2010; 646():135-46. PubMed ID: 20597007
[TBL] [Abstract][Full Text] [Related]
22. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
[No Abstract] [Full Text] [Related]
23. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.
Savidge TC; Pan WH; Newman P; O'brien M; Anton PM; Pothoulakis C
Gastroenterology; 2003 Aug; 125(2):413-20. PubMed ID: 12891543
[TBL] [Abstract][Full Text] [Related]
25. Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors.
von Eichel-Streiber A; Paik W; Knight K; Gisch K; Nadjafi K; Decker C; Bosnjak O; Cheknis A; Johnson S; von Eichel-Streiber C
Anaerobe; 2016 Oct; 41():91-103. PubMed ID: 27427464
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.
McDermott AJ; Falkowski NR; McDonald RA; Pandit CR; Young VB; Huffnagle GB
Immunology; 2016 Jan; 147(1):114-24. PubMed ID: 26455347
[TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
[TBL] [Abstract][Full Text] [Related]
28. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
29. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation.
Nam HJ; Kang JK; Kim SK; Ahn KJ; Seok H; Park SJ; Chang JS; Pothoulakis C; Lamont JT; Kim H
J Biol Chem; 2010 Oct; 285(43):32888-32896. PubMed ID: 20696758
[TBL] [Abstract][Full Text] [Related]
31. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
[TBL] [Abstract][Full Text] [Related]
33. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
34. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
Lamont JT
Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
[TBL] [Abstract][Full Text] [Related]
35. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
36. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.
Kyne L; Warny M; Qamar A; Kelly CP
Lancet; 2001 Jan; 357(9251):189-93. PubMed ID: 11213096
[TBL] [Abstract][Full Text] [Related]
37. Neutralization of Clostridium difficile toxin A using antibody combinations.
Demarest SJ; Hariharan M; Elia M; Salbato J; Jin P; Bird C; Short JM; Kimmel BE; Dudley M; Woodnutt G; Hansen G
MAbs; 2010; 2(2):190-8. PubMed ID: 20150758
[TBL] [Abstract][Full Text] [Related]
38.
Zhang P; Hong J; Yoon IN; Kang JK; Hwang JS; Kim H
J Microbiol Biotechnol; 2017 Jun; 27(6):1163-1170. PubMed ID: 28301919
[No Abstract] [Full Text] [Related]
39.
Kim YH; Kim H
J Microbiol Biotechnol; 2019 Oct; 29(10):1675-1681. PubMed ID: 31474101
[No Abstract] [Full Text] [Related]
40. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
